Genmab | GEN - Sales Revenues


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Genmab

Genmab reported DKK2.85B in Sales Revenues for its fiscal quarter ending in March of 2023.


Sales Change
Agios Pharmaceuticals AGIO:US USD 5.61M 1.3M
Almirall SA ALM:SM EUR 426.61M 10.02M
Amarin AMRN:US USD 85.98M 4.27M
Amgen AMGN:US USD 6.1B 734M
argenx SE ARGX:BB USD 219.14M 37.02M
Artemis Alpha ATS:LN GBP -15830000 10.03M
AstraZeneca AZN:LN USD 10.88B 328M
Bayer BAYN:GR EUR 14.39B 2.39B
BioMarin Pharmaceutical BMRN:US USD 596.42M 58.88M
Bluebird Bio BLUE:US USD 2.38M 2.32M
Demant A/s WDH:DC DKK 10.21B 711M
Exelixis EXEL:US USD 408.79M 15.13M
Fresenius Medical Care FME:GR EUR 4.7B 292.8M
Galapagos GLPG:NA EUR 187.17M 74.67M
Genmab GEN:DC DKK 2.85B 2.37B
GlaxoSmithKline GSK:LN GBP 6.95B 425M
GN Store Nord GN:DC DKK 4.21B 1.06B
Grifols GRF:SM EUR 1.56B 18.59M
Hikma Pharmaceutical HIK:LN USD 1.3B 91M
Immunogen IMGN:US USD 49.87M 8.7M
Insmed INSM:US USD 65.21M 5.91M
Lonza Group LONN:SW CHF 3.24B 259M
Merck MRK:GR EUR 5.29B 367M
Novartis NOVN:VX USD 13.21B 207M
Regeneron Pharmaceuticals REGN:US USD 3.16B 252.3M
Roche Holding ROG:VX CHF 30.99B 1.31B
Sanofi SAN:FP EUR 10.22B 503M
Seattle Genetics SGEN:US USD 519.72M 8.43M
UCB UCB:BB EUR 2.59B 333M